Source: Journal of Pharmacy and Pharmacology. Unidades: IQ, FCF
Subjects: LIPOPROTEÍNAS, LEUCEMIA
ABNT
TEIXEIRA, Raquel da Silva et al. Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors. Journal of Pharmacy and Pharmacology, v. 60, n. 10, p. 1287-1295, 2008Tradução . . Disponível em: https://doi.org/10.1211/jpp/60.10.0004. Acesso em: 08 out. 2024.APA
Teixeira, R. da S., Valduga, C. J., Benvenutti, L. A., Schreier, S., & Maranhão, R. C. (2008). Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors. Journal of Pharmacy and Pharmacology, 60( 10), 1287-1295. doi:10.1211/jpp/60.10.0004NLM
Teixeira R da S, Valduga CJ, Benvenutti LA, Schreier S, Maranhão RC. Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors [Internet]. Journal of Pharmacy and Pharmacology. 2008 ; 60( 10): 1287-1295.[citado 2024 out. 08 ] Available from: https://doi.org/10.1211/jpp/60.10.0004Vancouver
Teixeira R da S, Valduga CJ, Benvenutti LA, Schreier S, Maranhão RC. Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors [Internet]. Journal of Pharmacy and Pharmacology. 2008 ; 60( 10): 1287-1295.[citado 2024 out. 08 ] Available from: https://doi.org/10.1211/jpp/60.10.0004